RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..10 of 15 - per page Next page
Order by
CollaRx® & LiquiColl® Technologies
Collagen-based biodegradable matrices for localized drug delivery More
Robust Factor IX Minigene Expression Cassette: Gene Therapy for Inserting Genes that Require Liver-specific Expression
Robust Factor IX Minigene Expression Cassette: Gene Therapy for Inserting Genes that Require Liver-specific Expression More
Elucidation of Liver-Secreted Factor of 4 Kda (Lsf4): Implicated in Cholesterol and Obesity Related Diseases
Elucidation of Liver-Secreted Factor of 4 Kda (Lsf4): Implicated in Cholesterol and Obesity Related Diseases More
Compositions and Methods for Prognosis and Therapy of Liver Cancer
Compositions and Methods for Prognosis and Therapy of Liver Cancer More
Functional CMV Adenoviruses Expressing Wildtype and Mutant AMP-Activated Protein Kinase (AMPK): Gene Delivery to Experimental Diabetic Animals
Functional CMV Adenoviruses Expressing Wildtype and Mutant AMP-Activated Protein Kinase (AMPK): Gene Delivery to Experimental Diabetic Animals More
Hypothalamic Gene Transfer of BDNF for the Treatment of Metabolic and Related Disorders
Hypothalamic Gene Transfer of BDNF for the Treatment of Metabolic and Related Disorders More
A Novel Approach to the Prevention and Treatment of Type 2 Diabetes: Modulation of the Activity of Calpains
A Novel Approach to the Prevention and Treatment of Type 2 Diabetes: Modulation of the Activity of Calpains More
Obesity and Body Fat Distribution: Targets for Treatment of Obesity and Gene Expression Diagnosis of Obesity
Obesity and Body Fat Distribution: Targets for Treatment of Obesity and Gene Expression Diagnosis of Obesity More
Development of a Gene Therapy Treatment of Fatty Acid Metabolism Defects: Provision of Long-Term Treatment
Development of a Gene Therapy Treatment of Fatty Acid Metabolism Defects: Provision of Long-Term Treatment More
Gene Therapy of HBV Infection via Adeno-Associated Viral Vector Mediated Long Term Expression of Small Hairpin RNA (shjRNA)
Gene Therapy of HBV Infection via Adeno-Associated Viral Vector Mediated Long Term Expression of Small Hairpin RNA (shjRNA) More
Displaying 1..10 of 15 - per page Next page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Stakeholder Opinions: Gene Therapy - Gene therapy to deliver after 20 years of clinical development
Dec 2009 - 90 pages - $3,800
Coldwell Banker Gene Armstrong, Inc. - Company Capsule
Nov 2011 - 6 pages - $75
TaiGen Biotechnology Co., Ltd. - Product Pipeline Review - Q4 2010
Nov 2010 - 36 pages - $500
Preclinical Models: Innovative solutions to accelerate drug discovery and development
Feb 2010 - 131 pages - $3,835
Gene Signal International SA. – Product Pipeline Review – Q1 2011
Mar 2011 - 34 pages - $500
Gene Logic Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Mar 2011 - 31 pages - $250
Stakeholder Opinions: Novel Therapeutic Approaches in Cardiovascular Medicine - Lack of market prospects for biologics expose an opportunity for cell and gene therapies
Jul 2008 - 162 pages - $7,600
Tamir Biotechnology, Inc – Product Pipeline Review – Q4 2010
Dec 2010 - 15 pages - $500
RNA therapy: the next big thing after monoclonal antibodies?
Oct 2008 - 80 pages - $7,600
Pars Roos Biotechnology Co. - Product Pipeline Review - Q4 2010
Dec 2010 - 16 pages - $500
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us